Vivani Medical Files 8-K
Ticker: VANI · Form: 8-K · Filed: Sep 17, 2025 · CIK: 1266806
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
TL;DR
Vivani Medical filed an 8-K on 9/17/25. Standard reporting.
AI Summary
Vivani Medical, Inc. filed an 8-K on September 17, 2025, reporting other events and financial statements. The company, formerly known as Second Sight Medical Products Inc., is incorporated in Delaware and headquartered in Alameda, California.
Why It Matters
This filing indicates ongoing corporate reporting and potential updates regarding Vivani Medical's financial status and operational events.
Risk Assessment
Risk Level: low — This is a routine filing with no immediate indication of significant positive or negative events.
Key Players & Entities
- Vivani Medical, Inc. (company) — Registrant
- Second Sight Medical Products Inc. (company) — Former company name
- September 17, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Alameda, California (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Vivani Medical, Inc.?
The filing reports 'Other Events' and 'Financial Statements and Exhibits' as of September 17, 2025.
When was Vivani Medical, Inc. formerly known as?
Vivani Medical, Inc. was formerly known as Second Sight Medical Products Inc., with a name change date of October 10, 2003.
Where are Vivani Medical, Inc.'s principal executive offices located?
The principal executive offices are located at 1350 S. Loop Road, Alameda, California, 94502.
What is the Commission File Number for Vivani Medical, Inc.?
The Commission File Number for Vivani Medical, Inc. is 001-36747.
What is the SIC code for Vivani Medical, Inc. and what does it represent?
The SIC code is 3845, which represents 'ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS'.
Filing Stats: 513 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-09-17 09:27:05
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share VANI The Nasdaq Capital M
Filing Documents
- vani-20250917.htm (8-K) — 39KB
- ex991_1.htm (EX-99.1) — 46KB
- 0001753926-25-001510.txt ( ) — 274KB
- vani-20250917.xsd (EX-101.SCH) — 4KB
- vani-20250917_cal.xml (EX-101.CAL) — 1KB
- vani-20250917_def.xml (EX-101.DEF) — 1KB
- vani-20250917_lab.xml (EX-101.LAB) — 42KB
- vani-20250917_pre.xml (EX-101.PRE) — 29KB
- vani-20250917_htm.xml (XML) — 3KB
01
Item 8.01 Other Events. Record Date for Cortigent Spin-off On September 17, 2025, Vivani Medical, Inc. (the "Company") announced that the record date for the previously announced spin-off of Cortigent, Inc. ("Cortigent"), the Company's wholly-owned subsidiary, is set for October 8, 2025 (the "Record Date"). Cortigent is developing brain implant devices with neuromodulation technology. The Company's stockholders holding common stock of the Company as of the Record Date will receive common stock in Cortigent upon completion of the spin-off. The distribution date and share dividend ratio will be announced at a later date. A copy of the press release issued in connection with this announcement is being attached as Exhibit 99.1 to this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued by Vivani Medical, Inc. on September 17, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. VIVANI MEDICAL, INC. Date: September 17 , 2025 By: /s/ Donald Dwyer Name: Donald Dwyer Title: Chief Business Officer